Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Sema4, |
RCV002257202 | SCV002531610 | likely benign | Xeroderma pigmentosum | 2021-11-07 | criteria provided, single submitter | curation | |
Ambry Genetics | RCV002443277 | SCV002682019 | likely benign | Inborn genetic diseases | 2022-02-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV003718464 | SCV004512513 | likely benign | not provided | 2024-01-04 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004534001 | SCV004742478 | likely benign | ERCC2-related disorder | 2019-09-13 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |